Menu

Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research

Bio-Rad Laboratories, Inc. announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.

Jul 17, 2019
Bio-Rad

Messenger molecules such as cytokines are involved in the communication within the immune system and play a vital role in a variety of conditions including cancer and autoimmune diseases. Advancing discoveries in immunotherapy can be time consuming as existing immunoassay tools may not be tailored to cover specific targets including cytokine targets. The Bio-Plex Pro Human Immunotherapy Panel 20-plex covers biologically-researched cytokine targets that are associated with immunotherapy research.

About the Bio-Plex Pro Human Immunotherapy Panel 20-plex
The Bio-Plex Pro Human Immunotherapy Panel 20-plex is a ready-to-use, 1 x 96-well kit that contains premixed magnetic capture beads and detection antibodies, standards, and buffers that produce results for 20 different cytokines using only 12.5uL of sample. The Bio-Plex Panel maximizes laboratory efficiency by generating key actionable data in a single experiment. The kit is compatible with other Bio-Rad platforms including the Bio-Plex 200, Bio-Plex 3D Systems, as well as all other xMAP platforms.

October 2019

Brain Fog

Air Pollution May Cause Cognitive Decline

Marketplace

Sponsored Product Updates

Lonza’s MODA-ES™ Platform helps Nephron Pharmaceuticals move from paper to an EBR in nine months - Case study to be presented at 2019 ISPE Annual Meeting 
Lonza’s MODA-ES™ Platform helps Nephron Pharmaceuticals move from paper to an EBR in nine months - Case study to be presented at 2019 ISPE Annual Meeting 
·        Lonza has partnered with Nephron Pharmaceuticals Corporation to implement Lonza’s next-generation MODA-ES™ EBR Platform to streamline manufacturing compliance reporting· The MODA-ES™ Platform was implemented at Nephron in an aggressive nine-month time frame, improving operational efficiency and enabling a significant product line expansion·        Full results of the collaboration will be co-presented by Lonza and Nephron at the 2019 ISPE Annual Meeting & Expo in Las Vegas, Nevada
Understanding T-cell polyfunctionality: How single cell proteomics data drive CAR-T cell therapy research and development
Understanding T-cell polyfunctionality: How single cell proteomics data drive CAR-T cell therapy research and development
Vladimir Senyukov, Director of BioAnalytical Development at Precision Biosciences, talks about investigating T-cell cytokine production using single cell proteomics in order to unlock the therapeutic potential of allogenic CAR-T cells.
Zymo Research launches new RNA-Seq library prep kit
Zymo Research launches new RNA-Seq library prep kit
Zymo Research is excited to announce the fastest and easiest total RNA-Seq library prep kit that allows users to go from sample to sequencer in a single day!